These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

756 related items for PubMed ID: 7636864

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
    Komeda S, Takayama H, Suzuki T, Odani A, Yamori T, Chikuma M.
    Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
    [Abstract] [Full Text] [Related]

  • 23. In vitro and in vivo antitumour activity and cellular pharmacological properties of new platinum-iminoether complexes with different configuration at the iminoether ligands.
    Coluccia M, Nassi A, Boccarelli A, Giordano D, Cardellicchio N, Locker D, Leng M, Sivo M, Intini FP, Natile G.
    J Inorg Biochem; 1999 Oct; 77(1-2):31-5. PubMed ID: 10626350
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Circumvention of platinum resistance: structure-activity relationship for homologous series of ammine/amine platinum(II) complexes in L1210 cell lines.
    Yoshida M, Khokhar AR, Siddik ZH.
    Anticancer Drug Des; 1994 Oct; 9(5):425-34. PubMed ID: 7945726
    [Abstract] [Full Text] [Related]

  • 27. Cationic nonsymmetric transplatinum complexes with piperidinopiperidine ligands. Preparation, characterization, in vitro cytotoxicity, in vivo toxicity, and anticancer efficacy studies.
    Najajreh Y, Khazanov E, Jawbry S, Ardeli-Tzaraf Y, Perez JM, Kasparkova J, Brabec V, Barenholz Y, Gibson D.
    J Med Chem; 2006 Jul 27; 49(15):4665-73. PubMed ID: 16854072
    [Abstract] [Full Text] [Related]

  • 28. Circumvention of acquired tetraplatin resistance in a human ovarian carcinoma cell line by a novel trans platinum complex, JM335 [trans ammine (cyclohexylamine) dichloro dihydroxo platinum (IV)].
    Mellish KJ, Barnard CF, Kelland LR, Harrap KR.
    Int J Cancer; 1994 Oct 01; 59(1):65-70. PubMed ID: 7927906
    [Abstract] [Full Text] [Related]

  • 29. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
    Serebryanskaya TV, Yung T, Bogdanov AA, Shchebet A, Johnsen SA, Lyakhov AS, Ivashkevich LS, Ibrahimava ZA, Garbuzenco TS, Kolesnikova TS, Melnova NI, Gaponik PN, Ivashkevich OA.
    J Inorg Biochem; 2013 Mar 01; 120():44-53. PubMed ID: 23305964
    [Abstract] [Full Text] [Related]

  • 30. Antitumor and cellular pharmacological properties of a novel platinum(IV) complex: trans-[PtCl(2)(OH)(2)(dimethylamine) (isopropylamine)].
    Pérez JM, Kelland LR, Montero EI, Boxall FE, Fuertes MA, Alonso C, Navarro-Ranninger C.
    Mol Pharmacol; 2003 Apr 01; 63(4):933-44. PubMed ID: 12644595
    [Abstract] [Full Text] [Related]

  • 31. Synthesis and antitumour activity of platinum(II) and platinum(IV) complexes containing ethylenediamine-derived ligands having alcohol, carboxylic acid and acetate substituents. Crystal and molecular structure of [PtL4CL2].H20 where L4 is ethylenediamine-N,N'-diacetate.
    Jolley JN, Yanovsky AI, Kelland LR, Nolan KB.
    J Inorg Biochem; 2001 Jan 15; 83(2-3):91-100. PubMed ID: 11237267
    [Abstract] [Full Text] [Related]

  • 32. Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines.
    Yoshida M, Khokhar AR, Siddik ZH.
    Cancer Res; 1994 Jul 01; 54(13):3468-73. PubMed ID: 8012968
    [Abstract] [Full Text] [Related]

  • 33. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
    Kushev D, Gorneva G, Taxirov S, Spassovska N, Grancharov K.
    Biol Chem; 1999 Nov 01; 380(11):1287-94. PubMed ID: 10614821
    [Abstract] [Full Text] [Related]

  • 34. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
    Ali MS, Khan SR, Ojima H, Guzman IY, Whitmire KH, Siddik ZH, Khokhar AR.
    J Inorg Biochem; 2005 Mar 01; 99(3):795-804. PubMed ID: 15708801
    [Abstract] [Full Text] [Related]

  • 35. Intraliposomal conversion of lipophilic cis-bis-carboxylato-trans-R,R-1,2-diaminocyclohexane-platinum (II) complexes into cis-bis-dichloro-trans-R,R-1,2-diaminocyclohexane-platinum (II).
    Han I, Khokhar AR, Perez-Soler R.
    Cancer Chemother Pharmacol; 1996 Mar 01; 39(1-2):17-24. PubMed ID: 8995495
    [Abstract] [Full Text] [Related]

  • 36. Platinum(IV) complex with adamantylamine as nonleaving amine group: synthesis, characterization, and in vitro antitumor activity against a panel of cisplatin-resistant cancer cell lines.
    Zák F, Turánek J, Kroutil A, Sova P, Mistr A, Poulová A, Mikolin P, Zák Z, Kasná A, Záluská D, Neca J, Sindlerová L, Kozubík A.
    J Med Chem; 2004 Jan 29; 47(3):761-3. PubMed ID: 14736257
    [Abstract] [Full Text] [Related]

  • 37. Novel oximato-bridged platinum(II) di- and trimer(s): synthetic, structural, and in vitro anticancer activity studies.
    Scaffidi-Domianello YY, Legin AA, Jakupec MA, Roller A, Kukushkin VY, Galanski MS, Keppler BK.
    Inorg Chem; 2012 Jul 02; 51(13):7153-63. PubMed ID: 22691006
    [Abstract] [Full Text] [Related]

  • 38. New trans-platinum drugs with phosphines and amines as carrier ligands induce apoptosis in tumor cells resistant to cisplatin.
    Ramos-Lima FJ, Quiroga AG, García-Serrelde B, Blanco F, Carnero A, Navarro-Ranninger C.
    J Med Chem; 2007 May 03; 50(9):2194-9. PubMed ID: 17407274
    [Abstract] [Full Text] [Related]

  • 39. Synthesis, characterization, and antitumor activity of new chloroethylamine platinum complexes.
    Khokhar AR, Xu Q, Newman RA, Kido Y, Siddik ZH.
    J Inorg Biochem; 1992 Feb 15; 45(3):211-9. PubMed ID: 1634893
    [Abstract] [Full Text] [Related]

  • 40. Schedule dependency of orally administered bis-acetato-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) in vivo.
    McKeage MJ, Kelland LR, Boxall FE, Valenti MR, Jones M, Goddard PM, Gwynne J, Harrap KR.
    Cancer Res; 1994 Aug 01; 54(15):4118-22. PubMed ID: 8033145
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.